SIXTH MEETING OF THE WORKING GROUP ON MDR-TB OF THE STOP TB PARTNERSHIP
|
|
|
- Stephanie Primrose Washington
- 5 years ago
- Views:
Transcription
1 SIXTH MEETING OF THE WORKING GROUP ON MDR-TB OF THE STOP TB PARTNERSHIP SEPTEMBER 2007, TBILISI, GEORGIA.
2 SIXTH MEETING OF THE WORKING GROUP ON MDR-TB OF THE STOP TB PARTNERSHIP Introduction Emergence of XDR-TB in 2006 has highlighted more than ever the need for strengthening basic TB control and for adequate prevention and control of drug resistant TB. In 2007, major activities are being undertaken at global, regional and country levels to further strengthen basic TB control programmes and provide treatment and care to patients with MDR-TB and XDR-TB, as described in the Global MDR-TB and XDR-TB Response Plan ( This 6th Working Group (WG) meeting in 2007 will be crucial to build and sustain the political momentum for MDR- TB and XDR-TB control and strengthen and advance the activities of the Working Group and its subgroups. Objectives 1. Create further awareness around the global emergency of MDR-TB and XDR-TB in order to plan a much accelerated response by all individuals and agencies of the WG 2. Assess the lessons learned by National TB Control Programmes and GLC approved projects in the management of MDR-TB to inform policy formulations 3. Review progress achieved by the subgroups of the WG on MDR-TB and other relevant subgroups 4. Examine the progress in scaling-up MDR-TB control according to the Global Plan to Stop TB, and make decisions about ways to accelerate 5. Analyse challenges to scale up MDR-TB management and accelerate mobilization of resources by the StopTB community Experience in the management of MDR-TB, fostered by the work of the Green Light Committee (GLC) initiative, continues to grow as WHO and the Stop TB Partnership galvanizes processes with countries and technical partners. Nevertheless, improvements are needed to strengthen communication and information sharing between country projects, as recognized during the 5th meeting of the Working Group on MDR-TB held in Atlanta, US, 10 May, This meeting of the Working Group will bring together projects approved by the GLC to share not only their best practices, but also the challenges being faced while mainstreaming MDR-TB management into routine TB control, in line with the new Stop TB strategy. The lessons learned in this process will feed the debate on the strategic steps to be taken to accelerate the scale-up of MDR-TB management, according to Global Plan to Stop TB
3 PROGRAMME Thursday, 20 September. Opening Session 9:00-10:30 Welcoming remarks Thelma Tupasi, Chair of the Working Group (WG) on MDR-TB Key note address by Ms. Sandra Elisabeth Roelofs, First Lady of Georgia, Stop TB Ambassador. Opening address by H E David Tkeshelashvili Minister of Labour, Health and Social Affairs of Georgia From dreams to reality check on MDR-TB management scale up Dr Mario Raviglione, Director of the Stop TB Department, WHO Geneva Global MDR-TB and XDR-TB response Plan Dr Michael Kimerling, member of the Core Group of the WG on MDR-TB The challenge of mobilizing the resources to scale up MDR-TB management Dr Paul Nunn, Coordinator, TB/HIV and Drug Resistance, WHO Rise-up for Scale-up, from the Bottom-up! : Community driven civil society mobilization for MDR-TB (Now!) Case Gordon, World Care Council, and Simon Lobo, MISBAH Presentation of the agenda of the meeting Dr Thelma Tupasi, Chair of the Working Group on MDR-TB 10:30-10:50 COFFEE BREAK
4 Session 1 Managing MDR-TB: experiences at country level 10:50-11:20 ROOM Lessons learned in the scale-up of MDR-TB management Chair: Amy Bloom (USAID) Plenary presentations: Archil Salakaia (Georgia) and Lynne Vianzon (Philippines) 11:20-11:50 Lessons learned on management of second-line anti-tb drugs Chair: Amy Bloom (USAID) Plenary presentations: Jaime Bayona (Peru) and Vladislav Erokhin (Russia) 11:50-12:50 LILE SIMULTANEOUS BREAK-OUT SESSIONS a) Scaling-up MDR-TB management Chair : Jose Caminero (Spain) Facilitator: Salmaan Keshavjee (US) Rapporteur: Irina Sahakyan (WHO) b) Management of second-line anti-tb drugs Chair: Paul Zintl (US) Facilitator: Joel Keravec (Brasil) Rapporteur: Barbara Milani (Global Drug Facility) 12:50-13:50 LUNCH 13:50-14:20 14:20-14:50 Building laboratory capacity to deal with MDR-TB Chair: Zhao Yanlin (China) Plenary presentations: Moselinyane Letsie (Lesotho) and R O Brien (FIND); Francis Varaine ( Doctors without Borders / Medecines sans Frontiers) TB Infection Control: Chair: Zhao Yanlin (China) Martin Yagui (Peru) Bess Miller (US)
5 14:50-15:10 COFFEE BREAK 15:10-16:10 LILE SIMULTANEOUS BREAK-OUT SESSIONS a) Laboratory and drug resistant TB Chair: John Ridderhof (US CDC) Facilitator: Kitty Lambregts (KNCV) Rapporteur: Malgosia Grzemska (WHO) b) TB Infection Control Chair: Gunta Dravniece (Latvia) Facilitator: Bess Miller (US CDC) Rapporteur: Rose Pray (WHO) 16:10-17:00 TB infection control: no longer neglected Chair: Margaret Dalcolmo (Brasil) What s new in airborne infection control? Paul Jensen (US CDC) The WHO guidelines: what s the way forward? Bess Miller (US CDC) Friday, 21 September 9:00-9:30 Scaling-up patient and community participation in the Response to MDR/XDR. Chair: Khaled Abu Ramman (Jordan) Plenary presentations: Maxime Lunga (DR Congo) and Natalie Tarenec; Mamel Quelapio (Philippines) 9:30 10:00 Recording and Reporting in MDR-TB Chair: Khaled Abu Ramman (Jordan) Plenary presentations: Einar Heldal (LHL); Maria Rodriguez (Dominican Republic) 10:00-10:20 COFFEE BREAK 10:20-11:20 BREAK-OUT SESSIONS a) Scaling-up patient and community participation in the Response to MDR/XDR. Chair: Case Gordon (France) Facilitators: Natalie Tarenec (Ukraine) Rapporteur: Mick Matthews(Global Fund)
6 LILE b) Recording and reporting Chair: Joel Keravec (Brasil) Facilitator: Einar Heldal (LHL) Rapporteur: Matteo Zignol (WHO) 11:20-12:20 Lilly MDR-TB partnership: Supporting the development of capacity building for TB control Chair: Thelma Tupasi (Chair of the WG on MDR-TB) Plenary presentations: World Medical Association, International Council of Nurses, International Federation of Red Cross Societies, International Hospital Federation, Partners in Health, WHO 12:20-13:20 LUNCH Session 2 Translating best country practices into effective MDR-TB and XDR-TB response 13:20-14:50 Chair: Hamid Salim (Damian Foundation) 13:20-13:50 Update on Drug Resistance Surveillance Abigail Wright (WHO) 13:50-14:20 The updated WHO guidelines on the programmatic management of drug-resistant TB Karin Weyer (Chair of the Green Light Committee) 14:20-14:50 MDR-TB under the media spotlight Glenn Thomas (WHO) 14:50-15:10 COFFEE BREAK 15:10-17:30 Progress reports from the Subgroups of the WGs : Chair: Thelma Tupasi (Chair of the WG MDR-TB) 15:10-15:40 Green Light Committee Karin Weyer (Chair of the GLC)
7 15:40-16:10 Research on DR-TB Frank Cobelens (Chair of the sub-group on MDR-TB research, of the MDR-TB WG) 16:10-16:30 Management of second-line anti-tb drugs Robert Matiru (Manager of the GDF, Secretariat for the subgroup on drug management of the MDR-TB WG) 16:30-16:50 Laboratory Strengthening, John Ridderhof (Chair of the subgroup on laboratory strengthening of the DOTS Expansion WG) 16:50-17:10 Advocacy and social mobilization on MDR-TB, Nicole Schiegg (STP Secretariat for the advocacy and social mobilization WG) 17:10-17:30 TB Infection control Bess Miller (Chair of the subgroup on infection control of the TB-HIV WG) 9:00-10:20 Saturday, 22 September Session 3 Implementing the Global Response Plan to MDR-TB: what s next? Reports of the break-out sessions and plenary discussion Chair: Wang Xie Xiu (China) 9:00-9:40 Drug management 9:40-10:20 TB laboratory capacity 10:20-10:50 COFFEE BREAK 10:50-12:10 Reports of the break-out sessions and plenary discussion (continued) Chair: Frank Cobelens (KNCV) 10:50-11:30 Community-based care and participation
8 11:30-12:10 Recording and reporting 12:10-13:00 LUNCH 13:00-14:20 Reports of the break-out sessions and plenary discussion (continued) Chair: Michael Kimerling (US) 13:00-13:40 Infection control 13:40-14:20 Scaling up country-wide and globally 14:20-15:00 Thelma Tupasi (Chair of the MDR-TB WG) WG governance issues: New composition of the Core Group, election of a new chair and vice-chair Closing remarks
The Green Light Committee Progress Report
6 th Meeting of the Working Group on MDR-TB Tbilisi, Georgia: 20-22 September 2007 The Green Light Committee Progress Report Karin Weyer Rationale for the GLC 425,000 MDR-TB cases emerge every year Without
ANNUAL REPORT. Green Light Committee (January December 2005) The Green Light Committee of the Stop TB Working Group on DOTS-Plus
ANNUAL REPORT Green Light Committee (January December 2005) The Green Light Committee of the Stop TB Working Group on DOTS-Plus for Multidrug-Resistant Tuberculosis US Centers for Disease Control and Prevention,
Detailed programme. Wolfheze 2011 Consolidated and Urgent Actions to Prevent and Combat M/XDR TB
Detailed programme Wolfheze 2011 Consolidated and Urgent Actions to Prevent and Combat M/XDR TB 10 th WHO National TB Programme Managers Meeting, 15 th Wolfheze Workshops Jointly organized by World Health
Lilly MDR-TB Partnership: Capacity Building for TB Control. ICN: Strengthening nursing capacity in TB/MDR-TB. 21 September 2007, Tbilisi, Georgia
Lilly MDR-TB Partnership: Capacity Building for TB Control ICN: Strengthening nursing capacity in TB/MDR-TB 21 September 2007, Tbilisi, Georgia International Council of Nurses A federation of 129 national
WHO role in the introduction of new TB drugs and regimens: (2) Supporting introduction in countries
WHO role in the introduction of new TB drugs and regimens: (2) Supporting introduction in countries GDI/GLI Meeting Session 3 Geneva 27 th April 2015 Christian Lienhardt Global TB Programme World Health
Regional Meeting of National TB Control Programme Managers and Partners Bangkok, Thailand, September
Regional Meeting of National TB Control Programme Managers and Partners Bangkok, Thailand, 23-27 September Day 1: Monday 23 September 2013 08:00 09:00 Registration Session 1: Opening and introduction 09:00-10:00
5 th Regional TB Symposium 22/23 March 2016 Courtyard Marriott Hotel, Tbilisi, Georgia
Patients and TB: Improving treatment outcomes through a patient centered approach and access to new treatment 5 th Regional TB Symposium 22/23 March 2016 Courtyard Marriott Hotel, Tbilisi, Georgia DAY
TB Infection Control: Accomplishments, challenges, and setting priorities
TB Infection Control: Accomplishments, challenges, and setting priorities 16 th Core Group Meeting of the TB/HIV Working Group May 26-28, 2010 Almaty, Kazkhstan Bess Miller Chair, STOP TB Infection Control
PPM Subgroup Meeting: Lille
PPM Subgroup Meeting: Lille Increasing the effectiveness of the Stop TB Partnership in engaging all care providers A White Paper of the PPM Subgroup Requests of the Subgroup Read the document Endorse the
USG funding for partners to support countries in implementing Global Fund TB grants. Andrea Braza Godfrey, TBTEAM Secretariat 25 June 2010, Geneva
USG funding for partners to support countries in implementing Global Fund TB grants Andrea Braza Godfrey, TBTEAM Secretariat 25 June 2010, Geneva USG investment in technical assistance USG recognized importance
Management of patients with TB/HIV Gunta Kirvelaite
Management of patients with TB/HIV Gunta Kirvelaite Riga East Clinical hospital, Centre for tuberculosis and lung diseases. Head of outpatient department. MDR TB physician. WHO Collaborating Centre for
Public private mix for TB care and control
WHO/HTM/TB/2008.406 Public-Private Mix for TB Care and Control Report of the Fifth Meeting of the Subgroup on Public-Private Mix for TB Care and Control Cairo, Egypt 3-5 June 2008 WHO/HTM/TB/2008.406 Public
Regional GLC For Africa. Presented by Dr Norbert Ndjeka Member of AFRO rglc Committee
Regional GLC For Africa Presented by Dr Norbert Ndjeka Member of AFRO rglc Committee Year Before 2009 Activity History GLC : GDF, WHO, Technical partners, 2009 Revision of the MDR-TB global framework agreement
Programmatic Management of MDR-TB in China: Progress, Plan and Challenge
Programmatic Management of MDR-TB in China: Progress, Plan and Challenge Dr. Mingting Chen Researcher/Vice Director National Centre for Tuberculosis Control and Prevention of China CDC The People s Republic
Accelerating scale up of MDR-TB treatment in TB CARE countries
Accelerating scale up of MDR-TB treatment in TB CARE countries March 4-5, 2013, University Research Co., LLC, Bethesda, Maryland Objectives 1. To identify the bottlenecks to increasing the number of MDR-TB
Republic of Indonesia
Republic of Indonesia National Tuberculosis Program Remarks by the Honorable Ministry of Health on the Recommendation of the Tuberculosis Joint External Monitoring Mission 11-22 February 2013 First I would
PATIENT CENTERED APPROACH
BCARE I PATIENT CENTERED APPROACH Providing patient-centered care is crucial to achieving universal access to quality TB services for all people. TB CARE I responded to this need with the patient-centered
Infection Control and Tuberculosis in Perú Lessons Learned
Infection Control and Tuberculosis in Perú Lessons Learned Dr. Martin Yagui Moscoso (Dr. Paul Arthur Jensen) 1. Perú Area: 1,285,215 km 2 Population: 27 million 1. Health Services Health Service Hospitals
A people-centred model of TB care
A people-centred model of TB care 7th TB Symposium Ministry of Health of the Kyrgyz Republic and Médecins Sans Frontières, March 1, 2018 Dr Martin van den Boom, MD, MSc PH, Technical Officer, Joint TB,
Scaling up PPM: lessons from design and implementation of the Global Fund TB grants
Scaling up PPM: lessons from design and implementation of the Global Fund TB grants The Global Health Bureau, Office of Health, Infectious Disease and Nutrition (HIDN), US Agency for International Development,
Priority programmes and rural retention the example of TB. Karin Bergstrom Stop TB Department WHO, Geneva
Priority programmes and rural retention the example of TB Karin Bergstrom Stop TB Department WHO, Geneva In this presentation I will briefly: review the TB situation in the world discuss "evidence" on
Business Coalitions- Mediators for TB care and control
Business Coalitions- Mediators for TB care and control 1st Consultation to promote engagement of workplaces in TB care and control, 12 October 2009, Geneva Business Coalitions refers to Business Coalitions
Executive summary. 1. Background and organization of the meeting
Regional consultation meeting to support country implementation of the top ten indicators to monitor the End TB Strategy, collaborative TB/HIV activities and programmatic management of latent TB infection
Consolidated action plan to prevent and combat multidrug- and extensively drug-resistant tuberculosis in the WHO European Region
Regional Committee for Europe Sixty-first session EUR/RC61/15 + EUR/RC61/Conf.Doc./8 Baku, Azerbaijan, 12 15 September 2011 21 July 2011 111388 Provisional agenda item 6(f) ORIGINAL: ENGLISH Consolidated
IMCI. information. Integrated Management of Childhood Illness: Global status of implementation. June Overview
WHO/CHS/CAH/98.1B REV.1 1999 ORIGINAL: ENGLISH DISTR.: GENERAL IMCI information INTEGRATED MANAGEMENT OF CHILDHOOD ILLNESS (IMCI) DEPARTMENT OF CHILD AND ADOLESCENT HEALTH AND DEVELOPMENT (CAH) HEALTH
DOTS-PLUS: PRELIMINARY RESULTS AND EMERGING ISSUES
WHO/CDS/TB/2002.307 DOTS-PLUS: PRELIMINARY RESULTS AND EMERGING ISSUES Proceedings of the Meeting of the Stop TB Working Group on DOTS-Plus for MDR-TB Tallinn, Estonia 10 12 April 2002 World Health Organization
FEDERAL MINISTRY OF HEALTH NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME TERMS OF REFERENCE FOR ZONAL CONSULTANTS MARCH, 2017
FEDERAL MINISTRY OF HEALTH NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME EPIDEMIOLOGICAL ANALYSIS OF TUBERCULOSIS BURDEN AT NATIONAL AND SUB NATIONAL LEVEL (EPI ANALYSIS SURVEY) TERMS OF REFERENCE
Importance of the laboratory in TB control
World Health Organization Importance of the laboratory in TB control, January 2006 Importance of the laboratory in TB control Introduction Substantial progress has been made in recent years towards achieving
Dyah Erti Mustikawati
SCALING UP PPM IN INDONESIA Seventh Meeting of the Subgroup on Public-Private Mix for TB Care and Control 23-24 October 2011, Lille, France Dyah Erti Mustikawati NTP Manager MOH Indonesia Content Background
Framework for conducting reviews of tuberculosis programmes. Framework for conducting reviews of tuberculosis programmes
Framework for conducting reviews of tuberculosis programmes Framework for conducting reviews of tuberculosis programmes 1 WHO Library Cataloguing-in-Publication Data Framework for conducting reviews of
Health Cluster Coordination Meeting. Friday December 4, 2015, Kiev
Health Cluster Coordination Meeting Friday December 4, 2015, Kiev Agenda Polio vaccination update Humanitarian Response Plan 2016 Partners updates MHPSS update TB/HIV/AIDs and OST AOB BACKGROUND On 28
Ambulatory Care Day 1 for Multidrug Resistant Tuberculosis
Tuberculosis in 2017: Searching for new solutions in the face of new challenges 6th TB Symposium Ministry of Health of the Republic of Belarus, Republican Scientific and Practical Center for Pulmonology
Best practices in engagement of all health-care providers in the management of drug-resistant tuberculosis
Best practices in engagement of all health-care providers in the management of drug-resistant tuberculosis Best practices in engagement of all health-care providers in the management of drug-resistant
DOC An Action Plan for TB and Poverty. Introduction
An Action Plan for TB and Poverty DOC 1.06-7.1 Introduction The Global Plan to Stop TB 1 (2006-2015) aims to ensure equitable access to quality TB care for all people with TB, especially the poor and vulnerable.
GUIDE: Reporting Template_Tuberculosis
GUIDE: Reporting Template_Tuberculosis Narrative Report section Contract Number Project Title Contract Period Reporting Period Reporting Date (dd/mm/yyyy) explanation project start and end date in (DD/MM/YYYY)
Experiences from Peru; What have we learned? Dr. Martin Yagui Moscoso
Experiences from Peru; What have we learned? Dr. Martin Yagui Moscoso 1. PERU Area: 1,285,215 Km Total population: 28 millions Average life expectancy:69years Population living in poverty: 54% TB incidence:
Standards and Benchmarks for TB Surveillance and Vital Registration Systems: An Update
Standards and Benchmarks for TB Surveillance and Vital Registration Systems: An Update Emily Bloss WHO Global Task Force on TB Impact Measurement 29 October 2014 Goals of TB surveillance Monitor disease
National scholarship programme for foreign students, researchers and lecturers SCHOLARSHIP FOR STUDIES IN HIGHER EDUCATION INSTITUTION Guidelines 2018
National scholarship programme for foreign students, researchers and lecturers SCHOLARSHIP FOR STUDIES IN HIGHER EDUCATION INSTITUTION Guidelines 2018 Validated No. The purpose of the guidelines is to
Discussion notes: Breakout group on developing a Patient Centred Approach (PCA) to TB management
MDR-TB stakeholders meeting: 27 th -28 th October 2013 Discussion notes: Breakout group on developing a Patient Centred Approach (PCA) to TB management 28 th October: 14h00-15h30 Participants: Name, Surname
WHO policy on TB infection control in health care facilities, congregate settings and households.
WHO policy on TB infection control in health care facilities, congregate settings and households. Rose Pray Stop TB, WHO Why should we develop a policy on TB infection control? To guide countries on what
Role of Technical Assistance in the Establishment and Scale Up of Programmatic Management of Drug Resistant Tuberculosis (PMDT) in Ethiopia
Send Orders of Reprints at reprints@benthamscience.net 30 The Open Infectious Diseases Journal, 2013, 7, (Suppl 1: M3) 30-35 Open Access Role of Technical Assistance in the Establishment and Scale Up of
Tuberculosis control
SEA-TB-358 Distribution: General Tuberculosis control Report of a meeting of national programme managers and partners New Delhi, India, 10 14 November 2014 World Health Organization 2015 All rights reserved.
Role of National TB Program in LTBI Reseach. Dr Hung, Vietnam
Role of National TB Program in LTBI Reseach Dr Hung, Vietnam 1 TB Epidemiology in Viet Nam 12 th / 22 of the TB HBCs 14th / 27 MDR HBC. 2 Nguồn: Báo cáo WHO 2012 WHO 2014 TB RESEARCH IN VIET NAM Level
Initiation and scale-up of MDR-TB care in Ethiopia
Initiation and scale-up of MDR-TB care in Ethiopia Anne Goldfeld Global Health Committee Immune Disease Institute Harvard Medical School Harvard School of Public Health July 30, 2012 IOM Forum Washington
Tuberculosis as an Occupational Disease. Molebogeng Malotle
Tuberculosis as an Occupational Disease Molebogeng Malotle Introduction TB is a major global health problem Causes ill-health in millions of people each year Ranks the second leading cause of death from
Terms of Reference Approved 30 April 2015/ Revised 29 September 2016
COORDINATION DESK Terms of Reference Approved 30 April 2015/ Revised 29 September 2016 1. Introduction This document 1 describes the roles and working procedures for the Actors involved in the 10YFP Sustainable
Multidrug-resistant tuberculosis. Report of the sixth meeting of the Regional Advisory Committee (r-glc SEAR) Dhaka, Bangladesh, February 2015
Multidrug-resistant tuberculosis Report of the sixth meeting of the Regional Advisory Commiee (r-glc SEAR) Dhaka, Bangladesh, 14 16 February 2015 SEA-TB-360 Multidrug-resistant tuberculosis Report of the
REPORT OF THE NINTH MEETING
STRATEGIC AND TECHNICAL ADVISORY GROUP FOR TUBERCULOSIS (STAG-TB) REPORT OF THE NINTH MEETING 9-11 November 2009 WHO Headquarters Geneva, Switzerland Secretariat: World Health Organization 2009 All rights
Vienna, 27 November Madam President,
Statement of the G-77 and China at the 17 th Session of the UNIDO General Conference, delivered by H.E. Mr. Reza Najafi, Permanent Representative of the Islamic Republic of Iran and Chairman of the Vienna
Tuberculosis Regional Eastern European and Central Asian Project (TB-REP) Mid-term update
Tuberculosis Regional Eastern European and Central Asian Project (TB-REP) Mid-term update ABSTRACT The Tuberculosis Regional Eastern European and Central Asian Project (TB-REP) on strengthening health
MANAGING AND MONITORING THE TB PROGRAMME
MANAGING AND MONITORING THE TB PROGRAMME Dr Lindiwe Mvusi 14 April 2016 Outline Burden of disease of TB globally Progress towards MDG targets Burden of disease of TB globally Monitoring and evaluation
KEY ACTIVITIES IN TB CONTROL. Using Epidemiology for Data-Driven Decision-Making in Tuberculosis Programs February 24, 2016
BROADENING THE APPLICATION OF EPIDEMIOLOGY IN TUBERCULOSIS CONTROL Shama Desai Ahuja, PhD, MPH Director, Office of Sur veillance and Epidemiology Bureau of Tuberculosis Control New York City Depar tment
U.S. Funding for International Maternal & Child Health
April 2016 Issue Brief U.S. Funding for International Maternal & Child Health SUMMARY The U.S. government has a long history of supporting international maternal and child health (MCH) efforts, including
WORLD HEALTH ORGANIZATION. Strengthening nursing and midwifery
WORLD HEALTH ORGANIZATION FIFTY-SIXTH WORLD HEALTH ASSEMBLY A56/19 Provisional agenda item 14.11 2 April 2003 Strengthening nursing and midwifery Report by the Secretariat 1. The Millennium Development
Strategy of TB laboratories for TB Control Program in Developing Countries
Strategy of TB laboratories for TB Control Program in Developing Countries Borann SAR, MD, PhD, Institut Pasteur du Cambodge Phnom Penh, Cambodia TB Control Program Structure of TB Control Establish the
PROJECT INFORMATION DOCUMENT (PID) APPRAISAL STAGE Report No.: PIDA2678. Project Name. Region. Country
Public Disclosure Authorized Public Disclosure Authorized Public Disclosure Authorized Public Disclosure Authorized PROJECT INFORMATION DOCUMENT (PID) APPRAISAL STAGE Report No.: PIDA2678 Project Name
Summary of the Evaluation Study
Summary of the Evaluation Study 1.Outline of the Project Country: Indonesia Issue/Sector: Health Division in charge: Human Development Department, JICA Project title: Tuberculosis Control Project in the
Workshop Objective, Expectations and Agenda
Africa Regional Workshop on the Building of Sustainable National Greenhouse Gas Inventory Management Systems and the use of the 2006 IPCC Guidelines for National GHG Inventories Workshop Objective, Expectations
14TH CONGRESS OF 9 10 JUNE 2014, GENEVA, ROOM IX, ILO BUILDING
ASSOCIATION INTERNATIONALE DE L INSPECTION DU TRAVAIL INTERNATIONAL ASSOCIATION OF LABOUR INSPECTION ASOCIACION INTERNACIONAL DE L INSPECCION DE TRABAJO INTERNATIONALE VEREINIGUNG FUR ARBEITSINSPEKTION
Tuberculosis Diagnosis and Treatment Computer-based Training Package for Indonesia
FINAL REPORT Tuberculosis Diagnosis and Treatment Computer-based Training Package for Indonesia MARCH 2012 This final report was prepared University Research Co., LLC (URC) for review by the United States
Strengthening and Aligning Diagnosis and Treatment of Drug Resistant TB in India
Strengthening and Aligning Diagnosis and Treatment of Drug Resistant TB in India Dr K S Sachdeva Additional Deputy Director General Central TB Division Ministry of Health & Family Welfare Government of
Moving forward with regards to technical support needs and preparation for new funding model applications
Moving forward with regards to technical support needs and preparation for new funding model applications Christian Gunneberg TBTEAM secretariat Technical Support Coordination WHO Global TB Programme TBTEAM
The industrial competitiveness of Italian manufacturing
Milan, 27 January 2015 Where do we stand? Global perspectives on the Industrial Competitiveness of Italian manufacturing International Conference The industrial competitiveness of Italian manufacturing
Grant Aid Projects/Standard Indicator Reference (Health)
Examples of Setting Indicators for Each Development Strategic Objective Grant Aid Projects/Standard Indicator Reference (Health) Sector Development strategic objectives (*) Mid-term objectives Sub-targets
Introducing New TB Medicines and Regimens: Is Success Driven by Systems? Chinwe Owunna Antonia Kwiecien Dumebi Mordi
Introducing New TB Medicines and Regimens: Is Success Driven by Systems? Chinwe Owunna Antonia Kwiecien Dumebi Mordi Objectives Review key points on the global threat of drug resistant-tb Explore the importance
ANALYZING EFFICIENCY ACROSS HEALTH PROGRAMS: A WHO DIAGNOSTIC APPROACH
ANALYZING EFFICIENCY ACROSS HEALTH PROGRAMS: A WHO DIAGNOSTIC APPROACH Antonio Durán and Susan Sparkes Fiscal Space, Public Financial Management and Health Financing: Montreux, Switzerland 26-28 April
ECSA 10 TH ANNUAL BEST PRACTICES FORUM 10 TH 12 TH APRIL 2017 MT. MERU HOTEL. Lab Managers Side Meeting
ECSA 10 TH ANNUAL BEST PRACTICES FORUM 10 TH 12 TH APRIL 2017 MT. MERU HOTEL Global Fund Regional TB Lab Strengthening Project Grant Number: QPA-T- ECSA (890) Lab Managers Side Meeting 10 th April 2017
Health System Strengthening for Developing Countries
Health System Strengthening for Developing Countries Bob Emrey Health Systems Division USAID Bureau for Global Health 2009 Humanitarian Logistics Conference Georgia Tech Atlanta, Georgia February 19, 2009
Independent Evaluation of the Stop TB Partnership
Independent Evaluation of the Stop TB Partnership Final Report 21 April 2008 Copyright 2008 McKinsey & Company Table of contents Independent Evaluation of the Stop TB Partnership 1 Acknowledgements 3 Executive
Philippine Strategic TB Elimination Plan: Phase 1 (PhilSTEP1)
2017 2022 Philippine Strategic TB Elimination Plan: Phase 1 (PhilSTEP1) 24 th PhilCAT Convention August 16, 2017 Dr. Anna Marie Celina Garfin NTP-DCPB, Department of Health Reasons for developing the NTP
Strengthening tuberculosis surveillance: rationale and proposed areas of work
BACKGROUND DOCUMENT 2a Strengthening tuberculosis surveillance: rationale and proposed areas of work 2016 2020 Prepared by: Laura Anderson, Jaap Broekmans, Katherine Floyd, Philippe Glaziou, Babis Sismanidis,
Global Partnership for Enhanced Social Accountability (GPESA) December 19, 2011 World Bank
Global Partnership for Enhanced Social Accountability (GPESA) December 19, 2011 World Bank Why this Partnership? Increasing evidence that civil society s involvement improves public service delivery and
Edited by: ipierpaolo de Colombani. Review of the National Tuberculosis Programme in Belarus
Edited by: ipierpaolo de Colombani Review of the National Tuberculosis Programme in Belarus 10 21 October 2011 Address requests about publications of the WHO Regional Office for Europe to: Publications
Procurement and supply management report for the WHO European Region, high MDR-TB priority countries, 2013
Procurement and supply management report for the WHO European Region, high MDR-TB priority countries, 2013 ABSTRACT Drug-resistant TB poses a threat to population health in many countries throughout the
TB-Infection Control. International Consultants Training Course February 2008 Gaborone, Botswana
TB-Infection Control International Consultants Training Course 18-22 February 2008 Gaborone, Botswana Report by Dr Masoud Dara KNCV Tuberculosis Foundation TABLE OF CONTENTS ACKNOWLEDGEMENTS...2 OUTLINE
Extensive Review of TB Prevention, Care and Control Services in
Edited by: Masoud Dara Zaruhi Mkrtchyan Gayane Ghukasyan Extensive Review of TB Prevention, Care and Control Services in Armenia 21 April 4 May 2011 Mission Report Extensive Review of TB Prevention, Care
SESSION 1: INTRODUCTION TO DOT
FRANCIS J. CURRY NATIONAL TUBERCULOSIS CENTER SESSION 1: INTRODUCTION TO DOT INTRODUCTION In this 2-hour session, participants will learn the current scope of TB in the United States and in their own states
Improving the estimates of childhood TB disease burden and assessing childhood TB activities at country level
Improving the estimates of childhood TB disease burden and assessing childhood TB activities at country level Detjen A, Grzemska M, Graham SM, Sismanidis C Introduction Global estimates of disease burden
Investment, Enterprise and Development Commission Sixth session High-Level Segment on Youth Entrepreneurship for Development.
Investment, Enterprise and Development Commission Sixth session High-Level Segment on Youth Entrepreneurship for Development 28 April Geneva Entrepreneurship and productive capacity-building By James Zhan
OCB GATHERING: OPERATIONAL RESEARCH DAY / MSF BELGIUM GENERAL ASSEMBLY BRUSSELS, 1 & 2 JUNE 2018
OCB GATHERING: OPERATIONAL RESEARCH DAY / MSF BELGIUM GENERAL ASSEMBLY BRUSSELS, 1 & 2 JUNE 2018 OPERATIONAL RESEARCH DAY MSF Operational Centre Brussels INTRODUCTION Dear friends, It is my pleasure to
SUMMARY. CONTENTS I. Background.2 II. Decision and Recommendations of the Meeting 2 III. Summary of Proceedings 4 IV. Organization of the Meeting..
REPORT OF THE SECOND MEETING OF THE NETWORK FOR THE COORDINATION OF STATISTICAL TRAINING IN ASIA AND THE PACIFIC 4 March 2016 SIAP, 4 TH Floor JETRO-IDE Building, Chiba, Japan SUMMARY In March 2016, the
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs WHO/HTM/TB/2004.344 August 2004 For further information about tuberculosis or other communicable diseases, please contact
Personnel. Staffing of the Agency's Secretariat. Report by the Director General
Board of Governors General Conference GOV/2017/38-GC(61)/18 Date: 2 August 2017 General Distribution Original: English For official use only Item 8(b)(i) of the Board's provisional agenda (GOV/2017/33)
Meeting Report ELEVENTH NATIONAL TB PROGRAMME MANAGERS MEETING IN THE WESTERN PACIFIC REGION March 2017 Tokyo, Japan
Meeting Report ELEVENTH NATIONAL TB PROGRAMME MANAGERS MEETING IN THE WESTERN PACIFIC REGION 19 21 March 2017 Tokyo, Japan RS/2017/GE/04(JPN) English only WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR
SEVENTH MEETING OF THE CORE GROUP OF THE GLOBAL DRUG-RESISTANT TB INITIATIVE (GDI)
SEVENTH MEETING OF THE CORE GROUP OF THE GLOBAL DRUG-RESISTANT TB INITIATIVE (GDI) 9 June 2017 Geneva, Switzerland WHO/UNAIDS building, Geneva Table of Contents Background... 3 Meeting objectives... 3
International Trade. Virginia Economic Development Partnership. Presented By: Ellen Meinhart
International Trade Virginia Economic Development Partnership Presented By: Ellen Meinhart Benefits of Exporting 2 WHY DON T MORE COMPANIES SELL INTERNATIONALLY? OLD ASSUMPTION NEW ASSUMPTION Exporting
European Forum for Disaster Risk Reduction 1 (EFDRR) Concept Paper. Overview
European Forum for Disaster Risk Reduction 1 (EFDRR) Concept Paper Overview Overall Objective: 1. The European Forum for Disaster Risk Reduction is intended to serve as a forum to stimulate and facilitate
ASEAN Health Cooperation Relevant to the Healthy Development of Children. ASEAN Secretariat
Relevant to the Healthy Development of Children ASEAN Secretariat Health Cluster 1 on Promoting Healthy Lifestyle Health Priority 1: Prevention and Control of Non- Communicable Diseases (NCDs) All AMS
Management of drug-resistant tuberculosis Training for staff working at DR-TB management centres
Management of drug-resistant tuberculosis Training for staff working at DR-TB management centres Training modules Management of drug-resistant tuberculosis Training for staff working at DR-TB management
Meeting of the European Tuberculosis Laboratory Initiative (ELI) Core Group
Meeting of the European Tuberculosis Laboratory Initiative (ELI) Core Group Copenhagen, Denmark 25 February 2016 ABSTRACT The European Tuberculosis Laboratory Initiative (ELI) aims to strengthen tuberculosis
***** 13 February 2018 *****
Wednesday 14 and Thursday 15 February 2018 Meetings of NATO Defence Ministers NATO HQ - BRUSSELS MEDIA PROGRAMME ***** 13 February 2018 ***** 10:00 Welcome briefing by deputy Spokesperson and the head
PROGRAM YEAR 1 First and Second Quarterly Performance Monitoring Report October 1 st, 2010 March 31 st, 2011
PROGRAM YEAR 1 First and Second Quarterly Performance Monitoring Report October 1 st, 2010 March 31 st, 2011 May 16, 2011 TB CARE I Partners American Thoracic Society (ATS) FHI Japan Anti-Tuberculosis
Public health, innovation and intellectual property: global strategy and plan of action
EXECUTIVE BOARD EB126/6 126th Session 3 December 2009 Provisional agenda item 4.3 Public health, innovation and intellectual property: global strategy and plan of action Report by the Secretariat 1. The
Joint external evaluation of IHR Core Capacities of the Republic of Uganda. Executive summary June 26-30, 2017
Joint external evaluation of IHR Core Capacities of the Republic of Uganda Executive summary June 26-30, 2017 WHO/WHE/CPI/SUM/2017.39 World Health Organization 2017 Some rights reserved. This work is available
Minutes of the inaugural meeting of the Malaria Elimination Certification Panel
Malaria Policy Advisory Committee Meeting 11 13 April 2018, Geneva, Switzerland Background document for Session 3 Minutes of the inaugural meeting of the Malaria Elimination Certification Panel 13 14 December
Expert Consultation Meeting on Public Private Mix for Management of Drug Resistant Tuberculosis (PPM DR-TB)
Expert Consultation Meeting on Public Private Mix for Management of Drug Resistant Tuberculosis (PPM DR-TB) MEETING REPORT 23 24 June 2014 WHO Headquarters Geneva, Switzerland i World Health Organization
IHF Training Manual for TB and MDR-TB Control for Hospital/Clinic/Health Facility Managers Executive Summary 2
EXECUTIVE SUMMARY International Hospital Federation Immeuble JB SAY, 13, Chemin du Levant, 01210 Ferney Voltaire, France Tel: +33 (0) 450 42 60 00 / Fax: +33 (0) 450 42 60 01 Email: info@ihf-fih.org /
Government takes over TB medicines supply in Moldova: way forward
Government takes over TB medicines supply in Moldova: way forward Rita Seicas Programme Coordinator Center for Health Policies and Studies (PAS Center) Fighting Drug-Resistant TB in the 21st Century: Novel
Engaging women volunteers of high socioeconomic status in supporting socioeconomically disadvantaged tuberculosis patients in Chiang Rai, Thailand
Engaging women volunteers of high socioeconomic status in supporting socioeconomically disadvantaged tuberculosis patients in Chiang Rai, Thailand Lessons from the Field Jintana Ngamvithayapong-Yanai,
1 Introduction to ITC-26. Introduction to the ITC and DEPO. October 24 November 11, 2016 Albuquerque, New Mexico, USA Greg Baum
Introduction to the ITC and DEPO October 24 November 11, 2016 Albuquerque, New Mexico, USA Greg Baum L2 Learning Objectives After completing this module, you should be able to: Recognize the basic goal